Option Care Health (NASDAQ:OPCH) Hits New 52-Week High – Should You Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $36.34 and last traded at $36.41, with a volume of 375698 shares trading hands. The stock had previously closed at $36.03.

Analysts Set New Price Targets

OPCH has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Morgan Stanley lifted their price target on shares of Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Stephens upgraded shares of Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Barrington Research increased their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday. Finally, TD Cowen cut their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $37.50.

Option Care Health Price Performance

The stock’s fifty day moving average price is $31.66 and its 200-day moving average price is $29.54. The firm has a market cap of $5.68 billion, a PE ratio of 28.40, a price-to-earnings-growth ratio of 2.15 and a beta of 0.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the acquisition, the director owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Large investors have recently made changes to their positions in the stock. USA Financial Formulas purchased a new position in Option Care Health during the second quarter worth approximately $26,000. Cornerstone Planning Group LLC boosted its position in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after acquiring an additional 1,067 shares during the last quarter. Advisory Services Network LLC purchased a new stake in shares of Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health during the second quarter worth about $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health during the third quarter worth about $38,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.